Dr. Maegawa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
33 Whiting Hill Road
Eastern Maine Medical Center
Brewer, ME 04412Phone+1 207-973-7478Fax+1 207-973-7807
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2008 - 2011
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2005 - 2008
Federal University of Parana Faculty of MedicineClass of 2005
Certifications & Licensure
ME State Medical License 2012 - 2026
CA State Medical License 2011 - 2025
NJ State Medical License 2020 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 93 citationsUmbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1-1b study.Matthew S. Davids, Matthew S. Davids, Haesook T. Kim, Alyssa Nicotra, Alexandra Savell
The Lancet. Haematology. 2019-01-01 - 2 citationsMolecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis.Jerald P Radich, Matthew Wall, Susan Branford, Catarina D Campbell, Shalini Chaturvedi
Haematologica. 2023-06-01 - 30 citationsReduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxisRyotaro Nakamura, Joycelynne Palmer, Margaret R. O'Donnell, Tracey Stiller, Sandra H. Thomas
Leukemia Research. 2012-09-01
Lectures
- Phase II Trial of Combination of Elotuzumab, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- A Phase II Study of the Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone (RVD) Combination Therapy for Patients with Newly Diagnosed Mult...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Maine Patients and Researchers Fighting Cancer – Part 1February 2nd, 2017- Maine Patients and Researchers Fighting Cancer – Part 2February 2nd, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
